Vaxcyte, Inc. (PCVX)
55.39
-2.97
(-5.09%)
USD |
NASDAQ |
Nov 20, 16:00
55.16
-0.23
(-0.42%)
After-Hours: 20:00
Vaxcyte Price to Book Value : 3.322 for Nov. 20, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2026 | 3.322 |
| November 19, 2026 | 3.500 |
| November 18, 2026 | 3.510 |
| November 17, 2026 | 3.563 |
| November 16, 2026 | 3.695 |
| November 13, 2026 | 3.801 |
| November 12, 2026 | 3.88 |
| November 11, 2026 | 4.116 |
| November 10, 2026 | 3.980 |
| November 09, 2026 | 4.050 |
| November 06, 2026 | 3.832 |
| November 05, 2026 | 3.714 |
| November 04, 2026 | 3.939 |
| November 03, 2026 | 3.647 |
| November 02, 2026 | 3.636 |
| October 30, 2026 | 3.720 |
| October 29, 2026 | 3.755 |
| October 28, 2026 | 3.686 |
| October 27, 2026 | 3.639 |
| October 26, 2026 | 3.597 |
| October 23, 2026 | 3.624 |
| October 22, 2026 | 3.770 |
| October 21, 2026 | 3.792 |
| October 20, 2026 | 3.972 |
| October 19, 2026 | 3.819 |
| Date | Value |
|---|---|
| October 16, 2026 | 3.816 |
| October 15, 2026 | 3.915 |
| October 14, 2026 | 4.052 |
| October 13, 2026 | 4.006 |
| October 12, 2026 | 4.238 |
| October 09, 2026 | 4.281 |
| October 08, 2026 | 3.900 |
| October 07, 2026 | 4.016 |
| October 06, 2026 | 4.001 |
| October 05, 2026 | 4.428 |
| October 02, 2026 | 3.388 |
| October 01, 2026 | 3.362 |
| September 30, 2026 | 3.413 |
| September 29, 2026 | 2.976 |
| September 28, 2026 | 3.059 |
| September 25, 2026 | 2.951 |
| September 24, 2026 | 2.987 |
| September 23, 2026 | 2.966 |
| September 22, 2026 | 3.098 |
| September 21, 2026 | 3.093 |
| September 18, 2026 | 3.052 |
| September 17, 2026 | 3.169 |
| September 16, 2026 | 3.085 |
| September 15, 2026 | 3.108 |
| September 14, 2026 | 3.126 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Moderna, Inc. | 11.52 |
| Vir Biotechnology, Inc. | 1.586 |
| Anavex Life Sciences Corp. | 0.4876 |
| Revolution Medicines, Inc. | 14.52 |
| Foghorn Therapeutics, Inc. | -- |
Price to Book Value Related Metrics
| PEG Ratio | -0.104 |
| Price | 55.39 |
| Earnings Yield | -14.70% |
| Market Cap | 8.270B |
| PEGY Ratio | -0.104 |